Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,376) with videos related to
Page
of 138
Sort By:
The Journal of Clinical Investigation
|
August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R Burton, Laura J Pallett, Laura E McCoy, et al.
Nature
|
September 7, 2007
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J Hessell, Lars Hangartner, Meredith Hunter, et al.
BMJ (Clinical Research Ed.)
|
February 7, 2015
An occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trial
Catherine M Sackley, Marion F Walker, Christopher R Burton, et al.
Nature Communications
|
January 25, 2022
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies
Fortunato Ferrara, M Frank Erasmus, Sara D'Angelo, et al.
Journal of Human Virology
|
July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B
W Xu, B A Smith-Franklin, P L Li, et al.
Cell
|
September 27, 2014
Structural evolution of glycan recognition by a family of potent HIV antibodies
Fernando Garces, Devin Sok, Leopold Kong, et al.
Journal of Hepatology
|
January 22, 2013
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation
Scott W Biggins, James Trotter, Jane Gralla, et al.
Plos One
|
July 4, 2014
Transplanting supersites of HIV-1 vulnerability
Tongqing Zhou, Jiang Zhu, Yongping Yang, et al.
Science Immunology
|
January 23, 2026
Transient disruption of T cell help impairs germinal center dynamics and memory responses
Louise M C Webb, Helena A Carslaw, Jessica James, et al.
Journal of Virology
|
May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies
Nicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Page
of 138
Search research articles
Search
Showing results (1041-1050 of 1,376) with videos related to
Sort By:
Page
of 138
The Journal of Clinical Investigation
|
August 10, 2018
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R Burton, Laura J Pallett, Laura E McCoy, et al.
Nature
|
September 7, 2007
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J Hessell, Lars Hangartner, Meredith Hunter, et al.
BMJ (Clinical Research Ed.)
|
February 7, 2015
An occupational therapy intervention for residents with stroke related disabilities in UK care homes (OTCH): cluster randomised controlled trial
Catherine M Sackley, Marion F Walker, Christopher R Burton, et al.
Nature Communications
|
January 25, 2022
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies
Fortunato Ferrara, M Frank Erasmus, Sara D'Angelo, et al.
Journal of Human Virology
|
July 5, 2001
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B
W Xu, B A Smith-Franklin, P L Li, et al.
Cell
|
September 27, 2014
Structural evolution of glycan recognition by a family of potent HIV antibodies
Fernando Garces, Devin Sok, Leopold Kong, et al.
Journal of Hepatology
|
January 22, 2013
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation
Scott W Biggins, James Trotter, Jane Gralla, et al.
Plos One
|
July 4, 2014
Transplanting supersites of HIV-1 vulnerability
Tongqing Zhou, Jiang Zhu, Yongping Yang, et al.
Science Immunology
|
January 23, 2026
Transient disruption of T cell help impairs germinal center dynamics and memory responses
Louise M C Webb, Helena A Carslaw, Jessica James, et al.
Journal of Virology
|
May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies
Nicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Page
of 138